Clinical trial

Effect of Sulodexide in Early Diabetic Nephropathy

NCT00130208

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-08-01

PhasePHASE3

Study timeline

Study start (unknown)2005-08-01Date precision: month

Registry last updated2018-03-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathyunresolved

Interventions

SulodexideDRUG

PlaceboDRUG

Sponsors & collaborators

Keryx Biopharmaceuticalslead sponsor

Collaborative Study Group (CSG)collaborator

Mapped research locations

ChicagoIllinois, United States1 MelbourneVictoria, Australia1 GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00130208 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.